A federal whistleblower believes that the innovation cycle involving fundraising from venture capitalists and the pressure to hit revenue targets in the hopes of making an exit is the perfect recipe for corporate fraud.
“Are you ready to listen about the demise of our industry?” one med tech executive asked another at today’s LifeScience Alley luncheon. “Yes, I’m morbidly interested,” the other joked back. Such gallows humor pervades the medical device industry these days. And not without good reason. For months, I’ve heard panelist after panelist, expert after expert, […]
When it comes to managing inbound phone calls, underperformance has devastating cost implications.